We are live on ! Find out more

GoodRx Holdings

GDRX

Market cap $1.16B

3.39 USD

+0.04

1.19%

At close Updated Sep 11, 4:00 PM EDT

Pre-market

After hours

3.39

0.00

0%

1 day

1.19%

5 days

-3.14%

1 month

-10.79%

3 months

28.9%

6 months

50.67%

Year to date

23.27%

1 year

-19.67%

5 years

-92.33%

10 years

-93.29%

About: GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.

Employees: 697

Healthcare Health Information Services

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 60%

Neutral 33.3%

Negative 6.7%

GoodRx Covers Whole Households and Pets in New Prescription Plan

Prescription platform GoodRx has launched a new plan that covers a primary member and up to four dependents, including children, adult family members and pets, the company said in a Thursday (Sept. 3) press release.

GoodRx Covers Whole Households and Pets in New Prescription Plan

GoodRx offers health subscription for families, to launch as employee benefit in 2027

GoodRx, a prescription drug savings site, announced on Thursday a family healthcare subscription for access to common medical services and over 250 medications, and it plans to launch the program ‌as part of employer health benefits in 2027.

GoodRx offers health subscription for families, to launch as employee benefit in 2027

From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the trusted platform for prescription access and affordability in the U.S., today launched the GoodRx Companion Family Plan, expanding its everyday healthcare subscription to the entire family, including pets. As widening coverage gaps and rising out-of-pocket costs leave households paying more for care, the new plan brings Companion's free and low-cost prescriptions and savings on common healthcare services together in one affordabl.

From Kids to Canines: GoodRx Launches Companion Family Plan to Bring Healthcare Savings to the Whole Household

GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope

GoodRx has rebounded from $2.50 per share, showing renewed growth momentum and improved consumer traction. New offerings have contributed to GDRX's recent positive developments, but the stock's rapid appreciation reflects these improvements. I remain marginally more positive, yet GDRX still presents considerable risk, warranting a continued neutral rating.

Push for 'COMPETITIVE CASH PRICING': GoodRx CEO on TrumpRx partnership

GoodRx CEO Wendy Barnes discusses the company's partnership with TrumpRx and efforts to lower prescription drug costs on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #clamancountdown #goodrx #trumprx #wendybarnes #prescriptiondrugs #drugprices #healthcare #health #medicine #pharmacy #patients #consumer #trump #donaldtrump #donald_trump

Push for 'COMPETITIVE CASH PRICING': GoodRx CEO on TrumpRx partnership

GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript

GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript

GoodRx Holdings, Inc. (GDRX) Q2 2026 Earnings Call Transcript

GoodRx Q2 Earnings Call Highlights

GoodRx NASDAQ: GDRX reported second-quarter 2026 revenue of $200.4 million and adjusted EBITDA of $63.7 million, representing a 31.8% adjusted EBITDA margin, as growth in its Pharma Direct and subscription businesses offset pressure in prescription transaction revenue.

GoodRx Q2 Earnings Call Highlights

GoodRx and Oscar Health Tout Tech as Consumer Needs Change

The latest earnings from Oscar Health and GoodRx show both companies dealing with a changing customer base. The former company reported half-year earnings Thursday (Aug. 6) showing record profitability for the first six months of 2026, with revenues surging 70% to $4.9 billion.

GoodRx and Oscar Health Tout Tech as Consumer Needs Change

Zacks Investment Research

GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.09 per share a year ago.

GoodRx Holdings, Inc. (GDRX) Q2 Earnings Match Estimates

Zacks Investment Research

GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for GoodRx (GDRX) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

GoodRx (GDRX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

See News Rankings

Price charts implemented using Lightweight Charts™